FI935039A0 - Foerfarande och komposition foer minskning av ofoerdelaktiga effekter av aoldrande - Google Patents

Foerfarande och komposition foer minskning av ofoerdelaktiga effekter av aoldrande

Info

Publication number
FI935039A0
FI935039A0 FI935039A FI935039A FI935039A0 FI 935039 A0 FI935039 A0 FI 935039A0 FI 935039 A FI935039 A FI 935039A FI 935039 A FI935039 A FI 935039A FI 935039 A0 FI935039 A0 FI 935039A0
Authority
FI
Finland
Prior art keywords
ofoerdelaktiga
effekter
aoldrande
ageing
foerfarande och
Prior art date
Application number
FI935039A
Other languages
English (en)
Other versions
FI111219B (fi
FI935039A (fi
Inventor
Suresh I S Rattan
Original Assignee
Senetek Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27508530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI935039(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from NZ238210A external-priority patent/NZ238210A/en
Application filed by Senetek Plc filed Critical Senetek Plc
Publication of FI935039A0 publication Critical patent/FI935039A0/fi
Publication of FI935039A publication Critical patent/FI935039A/fi
Application granted granted Critical
Publication of FI111219B publication Critical patent/FI111219B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Ink Jet (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Stroboscope Apparatuses (AREA)
  • Measuring Volume Flow (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Medicinal Preparation (AREA)
  • Tea And Coffee (AREA)
  • Organic Insulating Materials (AREA)
  • Road Signs Or Road Markings (AREA)
FI935039A 1991-05-16 1993-11-15 Menetelmä ja koostumus nisäkkään ihon kosmeettisen ulkonäön parantamiseksi FI111219B (fi)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
CA002108369A CA2108369C (en) 1991-05-16 1991-05-16 Method and composition for ameliorating the adverse effects of aging
US9103466 1991-05-16
CA2108369 1991-05-16
PCT/US1991/003466 WO1992020341A1 (en) 1991-05-16 1991-05-16 Method and composition for ameliorating the adverse effects of aging
IL9820491 1991-05-21
IL9820491A IL98204A (en) 1991-05-16 1991-05-21 Cosmetic method and compositions for ameliorating the adverse effects of aging using 6-(substituted amino) purine cytokinins
NZ238210A NZ238210A (en) 1991-05-21 1991-05-21 Use of 6-(substituted amino) purine cytokinins for inhibiting effects of ageing on mammalian cells
NZ23821091 1991-05-21
CN91104472A CN1037235C (zh) 1991-05-16 1991-06-28 6-（取代氨基）嘌呤促细胞分裂素在制备抗衰老组合物中的用途
CN91104472 1991-06-28

Publications (3)

Publication Number Publication Date
FI935039A0 true FI935039A0 (fi) 1993-11-15
FI935039A FI935039A (fi) 1993-11-15
FI111219B FI111219B (fi) 2003-06-30

Family

ID=27508530

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935039A FI111219B (fi) 1991-05-16 1993-11-15 Menetelmä ja koostumus nisäkkään ihon kosmeettisen ulkonäön parantamiseksi

Country Status (18)

Country Link
EP (1) EP0584068B2 (fi)
JP (1) JP3103375B2 (fi)
KR (1) KR100196660B1 (fi)
CN (1) CN1037235C (fi)
AT (1) ATE185272T1 (fi)
AU (1) AU666836B2 (fi)
BR (1) BR9107307A (fi)
CA (1) CA2108369C (fi)
DE (1) DE69131692T3 (fi)
DK (1) DK0584068T4 (fi)
ES (1) ES2140392T5 (fi)
FI (1) FI111219B (fi)
GR (1) GR3032325T3 (fi)
IL (1) IL98204A (fi)
IN (1) IN172210B (fi)
NO (1) NO304814B1 (fi)
NZ (1) NZ247836A (fi)
WO (1) WO1992020341A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001031549A (ja) * 1999-07-14 2001-02-06 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料
EP1414951A2 (en) * 2000-11-25 2004-05-06 The University Of Leeds Plant growth regulation
DE10100122A1 (de) * 2001-01-03 2002-07-11 Henkel Kgaa Verfahren zur Bestimmung der Hautalterung in vitro
JP2002212052A (ja) * 2001-01-15 2002-07-31 Hajime Ito 外用組成物
EP1378224B8 (en) * 2001-04-13 2013-06-26 Otsuka Pharmaceutical Co., Ltd. Sugar intake promoters
CZ294535B6 (cs) * 2001-08-02 2005-01-12 Ústav Experimentální Botaniky Avčr Heterocyklické sloučeniny na bázi N6-substituovaného adeninu, způsoby jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
JP4567307B2 (ja) * 2003-08-25 2010-10-20 株式会社ノエビア 皮膚外用剤
CN100493506C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 化合物6-糠基氨基嘌呤在制备抗脑组织氧化损伤药物应用
CN100493507C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 化合物6-糠基氨基嘌呤制备抗雌性生殖器官损伤药物应用
CN100493508C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 化合物6-糠氨基嘌呤用于制备抗心肌缺血损伤药物的应用
CN100493510C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 6-糠氨基嘌呤用于制备治疗心肌组织氧化损伤药物的应用
CN100493509C (zh) * 2007-06-04 2009-06-03 西北农林科技大学 化合物6-糠基氨基嘌呤用于制备抗睾丸衰老药物的应用
CZ302225B6 (cs) * 2007-07-04 2010-12-29 Univerzita Palackého v Olomouci Substituované 6-anilinopurinové deriváty jako inhibitory cytokinin oxidasy a prípravky obsahující tyto slouceniny

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1587633A (fi) † 1968-07-04 1970-03-27
DD148889A3 (de) * 1974-08-19 1981-06-17 Forsch Die Gaerungsindustrie E Verfahren zur herstellung eiweissreicher hefen
JPS6019709A (ja) * 1983-07-14 1985-01-31 Tsunetaka Yokoyama 皮膚の老化防止及細胞分裂促進の化粧品の製造方法
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
JPH0619709A (ja) * 1992-04-29 1994-01-28 Sun Microsyst Inc パイプラインプロセッサを有するコンピュータシステム

Also Published As

Publication number Publication date
IN172210B (fi) 1993-05-01
KR100196660B1 (ko) 1999-06-15
AU666836B2 (en) 1996-02-29
JPH10510240A (ja) 1998-10-06
DE69131692D1 (de) 1999-11-11
NZ247836A (en) 1997-03-24
EP0584068A4 (fi) 1994-04-06
JP3103375B2 (ja) 2000-10-30
NO304814B1 (no) 1999-02-22
ATE185272T1 (de) 1999-10-15
EP0584068B2 (en) 2004-04-28
EP0584068B1 (en) 1999-10-06
DE69131692T2 (de) 2000-03-16
EP0584068A1 (en) 1994-03-02
NO934115D0 (no) 1993-11-15
DK0584068T3 (da) 2000-04-10
CN1068033A (zh) 1993-01-20
GR3032325T3 (en) 2000-04-27
NO934115L (no) 1994-01-17
FI111219B (fi) 2003-06-30
ES2140392T5 (es) 2004-10-16
CA2108369C (en) 2003-01-28
CN1037235C (zh) 1998-02-04
CA2108369A1 (en) 1992-11-17
IL98204A (en) 1994-11-11
WO1992020341A1 (en) 1992-11-26
ES2140392T3 (es) 2000-03-01
FI935039A (fi) 1993-11-15
BR9107307A (pt) 1994-06-14
DE69131692T3 (de) 2004-09-23
DK0584068T4 (da) 2004-06-14
AU8188491A (en) 1992-12-30

Similar Documents

Publication Publication Date Title
FI935039A0 (fi) Foerfarande och komposition foer minskning av ofoerdelaktiga effekter av aoldrande
NO930509L (no) Lavdensitets broennsement som kan fjernes med syre, og metoder
NO1994007I1 (no) Ketorolac/ 5-benzoyl-1,2-dihydro-3H-pyrrolo-[1,2-a]-pyrrol-1-karboksylsyre og dens farmasøytisk akseptable salter
FI98641B (fi) Fermentointiin liittyviä parannuksia
HU9300095D0 (en) New benzoic acid derivatives of cardio-vascular effect
GR3006275T3 (fi)
ZA913033B (en) N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic basis,their preparation and use
BG98124A (en) Active pyrrole-(2,3-)pyridine derivatives
EP0094790A3 (en) Herbicidal o-alkoxybenzenesulfonamides
SE9300758D0 (sv) Process for the production of clavulanic acid
ES2004333A4 (es) Proceso para preparar (s)(+)-4,4'-(1-metil-1,2-etanodiil)-bis (2,6-piperazinadiona).
NO880751D0 (no) Loeftestropp samt fremgangsmaate for dens fremstilling.
HK193695A (en) Semiconductor optical amplifier with shortened gain recovery time
IE820151L (en) Treating shock using meptazinol
NO882045D0 (no) Halvleder med kapasitiv utvelgelse av ladningsbaererne og integrert likespenningstilfoersel.
IT1205124B (it) Composto attivo nella terapia carciovascolare
SE7903042L (sv) Sett att framstella n-(polysackaridyl)-kveve-heterocykler, isynnerhet av pyrimidin- eller pyrinbaser
HUT37382A (en) New salts of cyclopropanecarboxylic acid and their application
NO912420L (no) Antiatherosklerotiske og antitrombotiske 1-benzopyran-4-oner og 2-amino-1,3-benzoksazin-4-oner.
DE59102829D1 (de) Ergolinderivate.
ES1002184Y (es) Cuna transformable en cama
ES8504801A1 (es) Nuevo procedimiento de obtencion de la 9(2-hidroxi-etoxi)-metil) guanina
FR2341308A1 (fr) Trimethoxyphenacyl-amines
IT1218067B (it) Aminoacilati del glicerol acetale
JPS5285186A (en) 6-aminopenicillanic acid derivatives